LATEST RELEASE10COMPANY
FEATURED NEWS
Fibralign Selected as a UCSF Rosenman Institute Innovator
The UCSF Rosenman Institute selected Fibralign for its innovative technology and patient impact.
Read full newsLatest company, clinical, regulatory and partnership updates from Fibralign.
The UCSF Rosenman Institute selected Fibralign for its innovative technology and patient impact.
Read full newsFibralign announced CE mark approval for BioBridge Collagen Matrix.
Read more →Fibralign executed a long-term distributor agreement with Terumo Corporation for Japan.
Read more →